Butomidor, 10 mg/ml süstelahus hobustele, koertele ja kassidele
Butomidor, 10 mg/ml süstelahus hobustele, koertele ja kassidele
Authorised
- Butorphanol tartrate
Product identification
Medicine name:
Butomidor, 10 mg/ml süstelahus hobustele, koertele ja kassidele
Active substance:
- Butorphanol tartrate
Target species:
-
Horse
-
Dog
-
Cat
Route of administration:
-
Intravenous use
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Butorphanol tartrate14.58/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intravenous use
-
Horse
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN02AF01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Available in:
-
Estonia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vetviva Richter GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetviva Richter GmbH
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1511
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Estonian (PDF)
Published on: 12/02/2025